{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:35Z","timestamp":1786985075095,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2010-18388"],"award-info":[{"award-number":["SAF2010-18388"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2013-44677-R"],"award-info":[{"award-number":["SAF2013-44677-R"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["FIS PI12\/00506"],"award-info":[{"award-number":["FIS PI12\/00506"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["FIS PI12\/00969"],"award-info":[{"award-number":["FIS PI12\/00969"]}]},{"name":"SPANISH AIDS Research Network","award":["RD12\/0017\/0015"],"award-info":[{"award-number":["RD12\/0017\/0015"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Region Development Fund"},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["BMS AI471-041"],"award-info":[{"award-number":["BMS AI471-041"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AIM-HIV Network of Excellence of the EU","award":["HEALTH-F3-2012-305938"],"award-info":[{"award-number":["HEALTH-F3-2012-305938"]}]},{"name":"Agence Nationale de Recherches sur le SIDA et les H\u00e9patites Virales","award":["ANRS AO2014-2"],"award-info":[{"award-number":["ANRS AO2014-2"]}]},{"name":"European FP7-HEALTH"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["MPY 1371\/12"],"award-info":[{"award-number":["MPY 1371\/12"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Economy and Competitiveness"},{"name":"European Union Programme Health"},{"name":"European FP7-HEALTH"},{"name":"Spanish Health Institute Carlos III"},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.bcp.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T20:47:24Z","timestamp":1454532444000},"page":"30-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells"],"prefix":"10.1016","volume":"106","author":[{"given":"Mercedes","family":"Bermejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosa","family":"L\u00f3pez-Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Climent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Descours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ambrosioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rodr\u00edguez-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Rus-Bercial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monsef","family":"Benkirane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Alcam\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Coiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.02.002_b0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.279.6.450","article-title":"Improved survival among HIV-infected individuals following initiation of antiretroviral therapy","volume":"279","author":"Hogg","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2016.02.002_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0015","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2016.02.002_b0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/infdis\/jit307","article-title":"Early treatment and HIV-1 reservoirs: a stitch in time?","volume":"208","author":"Henrich","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2016.02.002_b0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(14)70893-X","article-title":"Research on very early ART in neonates at risk of HIV infection","volume":"14","author":"Shah","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bcp.2016.02.002_b0030","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1073\/pnas.1406663111","article-title":"Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1","volume":"111","author":"Hill","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.02.002_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/QCO.0000000000000026","article-title":"Emerging strategies to deplete the HIV reservoir","volume":"27","author":"Archin","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bcp.2016.02.002_b0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033948","article-title":"Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection","volume":"7","author":"Ananworanich","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2016.02.002_b0050","doi-asserted-by":"crossref","first-page":"10056","DOI":"10.1128\/JVI.01046-14","article-title":"Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells","volume":"88","author":"Buzon","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2016.02.002_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2015.02.009","article-title":"Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription","author":"Bermejo","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2016.02.002_b0060","doi-asserted-by":"crossref","first-page":"27363","DOI":"10.1074\/jbc.M110.210443","article-title":"Protein kinase Ctheta is a specific target for inhibition of the HIV type 1 replication in CD4+ T lymphocytes","volume":"286","author":"Lopez-Huertas","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.002_b0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.phrs.2007.04.009","article-title":"Protein kinase C theta (PKCtheta): a key player in T cell life and death","volume":"55","author":"Hayashi","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2016.02.002_b0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ni.2121","article-title":"The kinase GLK controls autoimmunity and NF-kappaB signaling by activating the kinase PKC-theta in T cells","volume":"12","author":"Chuang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0075","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ni.2120","article-title":"A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28","volume":"12","author":"Kong","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.cb.07.110191.001353","article-title":"The role of tyrosine protein phosphorylation in lymphocyte activation","volume":"7","author":"Sefton","year":"1991","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.bcp.2016.02.002_b0085","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.183.3.1053","article-title":"Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes","volume":"183","author":"van Oers","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/384484a0","article-title":"Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation","volume":"384","author":"Yamaguchi","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.002_b0095","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0092-8674(92)90428-F","article-title":"Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor","volume":"70","author":"Straus","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2016.02.002_b0100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/cyto.a.22070","article-title":"TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues","volume":"81","author":"Nyakeriga","year":"2012","journal-title":"Cytometry A"},{"key":"10.1016\/j.bcp.2016.02.002_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fimmu.2012.00197","article-title":"Regulation of PKC-theta function by phosphorylation 1 in T cell receptor signaling","volume":"3","author":"Wang","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0110","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/88765","article-title":"Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation","volume":"2","author":"Bi","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0115","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrmicro2223","article-title":"Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs","volume":"7","author":"Coiras","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bcp.2016.02.002_b0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2010.04.008","article-title":"PKCtheta is necessary for efficient activation of NFkappaB, NFAT, and AP-1 during positive selection of thymocytes","volume":"132","author":"Gruber","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bcp.2016.02.002_b0125","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1074\/jbc.275.5.3603","article-title":"Regulation of protein kinase Ctheta function during T cell activation by Lck-mediated tyrosine phosphorylation","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.002_b0130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20020234","article-title":"Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells","volume":"197","author":"Pfeifhofer","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000956","article-title":"Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step","volume":"6","author":"Harmon","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2016.02.002_b0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/QAD.0000000000000073","article-title":"The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients","volume":"28","author":"Pogliaghi","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.bcp.2016.02.002_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1999.4732","article-title":"Src family tyrosine kinases and growth factor signaling","volume":"254","author":"Abram","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2016.02.002_b0150","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1021\/jm060727j","volume":"49","author":"Das","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2016.02.002_b0155","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1517\/14656566.8.18.3257","article-title":"Dasatinib for the treatment of philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure","volume":"8","author":"Hochhaus","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bcp.2016.02.002_b0160","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/leu.2010.11","article-title":"Lck is a key target of imatinib and dasatinib in T-cell activation","volume":"24","author":"Lee","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2016.02.002_b0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/blood-2006-07-035493","article-title":"Dasatinib (BMS-354825) is active in philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure","volume":"109","author":"Quintas-Cardama","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2016.02.002_b0170","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0175","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/hep.26223","article-title":"Molecular subtype and response to dasatinib, an Src\/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro","volume":"57","author":"Finn","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2016.02.002_b0180","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood-2007-04-084814","article-title":"Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation","volume":"111","author":"Schade","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2016.02.002_b0185","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3109\/10428194.2012.656626","article-title":"Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complications","volume":"53","author":"Rodriguez","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcp.2016.02.002_b0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clim.2008.02.006","article-title":"The Src\/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro","volume":"127","author":"Blake","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1742-4690-9-87","article-title":"SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells","volume":"9","author":"Descours","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.bcp.2016.02.002_b0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2236","article-title":"SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates","volume":"13","author":"Lahouassa","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0205","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm.3626","article-title":"The ribonuclease activity of SAMHD1 is required for HIV-1 restriction","volume":"20","author":"Ryoo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0210","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.celrep.2013.03.017","article-title":"Phosphorylation of SAMHD1 by cyclin A2\/CDK1 regulates its restriction activity toward HIV-1","volume":"3","author":"Cribier","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2016.02.002_b0215","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.002_b0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.133.1.123","article-title":"The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level","volume":"133","author":"Weiss","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0225","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1016\/j.bmcl.2006.08.132","article-title":"The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)","volume":"16","author":"Sabat","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2016.02.002_b0230","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2016.02.002_b0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jmv.20770","article-title":"A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1","volume":"79","author":"Garcia-Perez","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2016.02.002_b0240","doi-asserted-by":"crossref","first-page":"33409","DOI":"10.1074\/jbc.M111.279596","article-title":"Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5)","volume":"286","author":"Garcia-Perez","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.02.002_b0245","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/382833a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell-line-adapted HIV-1","volume":"382","author":"Oberlin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.002_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000057","article-title":"Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction","volume":"4","author":"Sharova","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2016.02.002_b0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12977-015-0177-1","article-title":"A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity","volume":"12","author":"Garcia-Perez","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.bcp.2016.02.002_b0260","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/nar\/gkq037","article-title":"Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon","volume":"38","author":"Lopez-Huertas","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2016.02.002_b0265","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/sj.onc.1202455","article-title":"Expression of IkappaBalpha in the nucleus of human peripheral blood T lymphocytes","volume":"18","author":"Lain de","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2016.02.002_b0270","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2016.02.002_b0275","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-1759(94)90236-4","article-title":"Determination of lymphocyte division by flow cytometry","volume":"171","author":"Lyons","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bcp.2016.02.002_b0280","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"Connor","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.bcp.2016.02.002_b0285","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity","volume":"69","author":"He","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2016.02.002_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058927","article-title":"Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals","volume":"8","author":"Guardo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2016.02.002_b0295","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1016\/j.vaccine.2009.08.021","article-title":"Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine","volume":"27","author":"Lopez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.bcp.2016.02.002_b0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2008.07.032","article-title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication","volume":"135","author":"Konig","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2016.02.002_b0305","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1084\/jem.164.1.280","article-title":"Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus","volume":"164","author":"Folks","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0310","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/87979","article-title":"A quantitative assay for HIV DNA integration in vivo","volume":"7","author":"Butler","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0315","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1128\/JVI.77.18.10119-10124.2003","article-title":"Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus","volume":"77","author":"Brussel","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2016.02.002_b0320","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1128\/JVI.80.8.3712-3720.2006","article-title":"Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex","volume":"80","author":"Dismuke","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2016.02.002_b0325","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells","volume":"18","author":"Baldauf","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0330","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","article-title":"Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection","volume":"95","author":"Chun","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.02.002_b0335","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.274.5289.985","article-title":"Quantitative image analysis of HIV-1 infection in lymphoid tissue","volume":"274","author":"Haase","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.02.002_b0340","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.immunol.17.1.625","article-title":"Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues","volume":"17","author":"Haase","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2016.02.002_b0345","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"Whitney","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.002_b0350","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1126\/science.286.5443.1353","article-title":"Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells","volume":"286","author":"Zhang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.02.002_b0355","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0360","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood-2012-11-465625","article-title":"Interleukin-7 promotes HIV persistence during antiretroviral therapy","volume":"121","author":"Vandergeeten","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2016.02.002_b0365","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/518250","article-title":"Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus","volume":"195","author":"Chun","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bcp.2016.02.002_b0370","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jac\/dks533","article-title":"Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts","volume":"68","author":"Hocqueloux","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.02.002_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study","volume":"9","author":"Saez-Cirion","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bcp.2016.02.002_b0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1742-4690-8-97","article-title":"Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy","volume":"8","author":"Salgado","year":"2011","journal-title":"Retrovirology"},{"key":"10.1016\/j.bcp.2016.02.002_b0385","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.002_b0390","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcp.2016.02.002_b0395","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"Doitsh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2016.02.002_b0400","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature12940","article-title":"Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection","volume":"505","author":"Doitsh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.02.002_b0405","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1243640","article-title":"IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV","volume":"343","author":"Monroe","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.02.002_b0410","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1128\/JVI.02291-13","article-title":"SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication","volume":"87","author":"Kim","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2016.02.002_b0415","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0420","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.20041196","article-title":"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract","volume":"200","author":"Mehandru","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2016.02.002_b0425","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/QAD.0b013e32834b9658","article-title":"Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir","volume":"25","author":"Koelsch","year":"2011","journal-title":"AIDS"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T14:58:45Z","timestamp":1692197925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":85,"alternative-id":["S0006295216000654"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.02.002","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}